Expert Opinion on Drug Safety

Thimerosal-containing vaccines: evidence versus public apprehension
pp. 1-4(4)
Author: DeStefano, Frank

Aprotinin and renal dysfunction: what does history teach us?
pp. 5-7(3)
Author: Augoustides, John G

Cisplatin-vinorelbine chemotherapy in non-small cell lung cancer is safe and well tolerated: results of a retrospective Hungarian clinical data analysis
pp. 9-14(6)
Authors: Szilasi, Mária; Müller, Veronika; Juhász, Erzsébet; Magyar, Pál; Budai, Marianna; Tamási, Lilla

How safe is the use of thiazolidinediones in clinical practice?
pp. 15-32(18)
Authors: Rizos, CV; Elisaf, Moses; Mikhailidis, DP; Liberopoulos, EN

Glucocorticoids and the risk of osteoporosis
pp. 33-47(15)
Authors: Caplan, Liron; Saag, Kenneth G

Ultrasound contrast agents: balancing safety versus efficacy
pp. 49-56(8)
Authors: Main, Michael L; Goldman, Jonathan H; Grayburn, Paul A

Prolongation in QT interval is not predictive of Ca²⁺-dependent arrhythmias: implications for drug safety
pp. 57-72(16)
Authors: Pasquié, Jean-Luc; Richard, Sylvain

Drug-induced immune hemolytic anemia
pp. 73-79(7)
Author: Salama, Abdulgabar

The efficacy and safety of ixabepilone monotherapy in the treatment of breast and gynecologic malignancies
pp. 81-88(8)
Authors: Gupta, Divya; Mani, Sridhar

Memantine: a comprehensive review of safety and efficacy
pp. 89-109(21)
Author: Kavirajan, Harish

Amoxicillin and amoxicillin plus clavulanate: a safety review
pp. 111-118(8)
Authors: Salvo, Francesco; De Sarro, Angelina; Caputi, Achille Patrizio; Polimeni, Giovanni

Rabeprazole: a pharmacologic and clinical review for acid-related disorders
pp. 119-126(8)
Authors: Dadabhai, Alia; Friedenberg, Frank K

Erratum
pp. 127-127(1)